Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01008072
Recruitment Status : Unknown
Verified November 2009 by Assaf-Harofeh Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : November 5, 2009
Last Update Posted : November 5, 2009
Information provided by:
Assaf-Harofeh Medical Center

Brief Summary:
The methods of detoxification under general anesthesia have been criticized because of limited data on safety and long-term follow-up. Premedication with buprenorphine has been advocated to improve safety. In current study we want to evaluate the importance of buprenorphine preparation in rapid opioid detoxification process, under general anesthesia.

Condition or disease
Opioid Addiction

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case Control
Time Perspective: Retrospective
Study Start Date : December 2009
Estimated Primary Completion Date : December 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

without buprenorphine preparation
with buprenorphine preparation

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All opioid addicted patients who wants to undergo rapid detoxification under general anesthesia.

Inclusion Criteria:

  • Opioid addiction

Exclusion Criteria:

  • Age < 18 Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01008072

Contact: Murat Bahar, MD 97289778080

Anesthesiology department, Assaf-Harofeh MC Not yet recruiting
Beer-Yaakov, Zrifin, Israel, 70300
Contact: Murat Bahar, MD    97289778080   
Principal Investigator: Murat Bahar, MD         
Sponsors and Collaborators
Assaf-Harofeh Medical Center

Responsible Party: Murat Bahar, Assaf-Harofeh MC Identifier: NCT01008072     History of Changes
Other Study ID Numbers: 173/09
First Posted: November 5, 2009    Key Record Dates
Last Update Posted: November 5, 2009
Last Verified: November 2009

Additional relevant MeSH terms:
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Narcotic Antagonists